22 Jan 2021

Reply

Tender// Various Finished Dosage Formulations needed in France [ENA09560]
Valenciennes Hospital Center is looking for supplies of Various Finished Dosage Formulations. The deadline is 12-Feb-2021.
1. Midodrine (2.5 mg) Tablet. The required quantity is 28,8445 units.
2. Ambrisentan (5 mg and 10 mg) Tablet. The required quantity is 8,444 units and 18,845 units respectively.
3. Metronidazole (250 mg and 500 mg) Tablet. The required quantity is 29,900 units and 82,238 units respectively.
4. Cinacalcet (30 mg and 60 mg) Tablet. The required quantity is 29,908 units and 2,977 units respectively.
5. Deferiprone (1000 mg and 500 mg) Tablet. The required quantity is 17,128 units and 19,477 units respectively.
6. Entecavir (0.5 mg and 1 mg) Tablet. The required quantity is 1,948 units and 107 units respectively.
7. Cyamemazine (25 mg) Tablet. The required quantity is 909,429 units.
8. Famotidine (20 mg and 40 mg) Tablet. The required quantity is 3,928 units and 5,256 units respectively.
9. Baclofen (0.05 mg/ ml ampoule and 2 mg/ ml) Injection. The required quantity is 97 units and 801 units respectively.
10. Atovaquone (750 mg/ 5ml) Oral Suspension. The required quantity is 340 units.

Comments :

vishvesh.shaishav@gmail.com

We are focussed on developing new manufacturing technologies, including custom synthesis of new moleculepharma intermediate, catalyst, bulk drugs, pharma API, pharma chemicals, active pharmaceutical ingredients, pharmaceutical pellets,additives, contract manufacturing, chemicals. We began in the field of specialty intermediates for pharmaceutical applications and developed our own purification technologies for manufacturing highly pure intermediates. And Pharmaceutical API At a later stage, we integrated forward to manufacture finished formulations for both veterinary and human consumption. Due to our completely integrated operations in the pharmaceutical sector, we continuously learn about the quality parameters for an API based on the performance of the finished formulation in order to quality their Bioequivalence Studies.
We have established finished formulation lines in South Asian and Latin American countries. It is our vision to achieve worldwide recognition as an excellent business partner from India by providing our customers with superior quality products at highly affordable prices and following that up with reliable service consistently, thereby giving them an unparalleled experience.
Our focus lies in developing new production technologies with a keen interest in frugal innovation in order to gain a competitive edge over others. We specialize in the custom synthesis of molecules and work with many reputed companies around the world on an OEM basis.pharmaceutical pellets,Intermidiates
Our finished formulations from WHO-GMP and EU-GMP units are registered/being registered in 26 countries within Asia, Europe, North America, Latin America and Africa continents including Peru, Panama, Ecuador, Chile, Curaçao, Suriname, Haiti, Aruba, Trinidad, Tobago, Philippines, Myanmar, Laos, Malaysia, Thailand, Indonesia, Hong Kong, Vietnam, Sri Lanka, Maldives, Brunei, Nepal, China, Russia, Croatia, Venezuela and Bhutan.
vishvesh.shaishav@gmail.com

22:35,  22 Jan 2021

vishvesh.shaishav@gmail.com

We are focussed on developing new manufacturing technologies, including custom synthesis of new moleculepharma intermediate, catalyst, bulk drugs, pharma API, pharma chemicals, active pharmaceutical ingredients, pharmaceutical pellets,additives, contract manufacturing, chemicals. We began in the field of specialty intermediates for pharmaceutical applications and developed our own purification technologies for manufacturing highly pure intermediates. And Pharmaceutical API At a later stage, we integrated forward to manufacture finished formulations for both veterinary and human consumption. Due to our completely integrated operations in the pharmaceutical sector, we continuously learn about the quality parameters for an API based on the performance of the finished formulation in order to quality their Bioequivalence Studies.
We have established finished formulation lines in South Asian and Latin American countries. It is our vision to achieve worldwide recognition as an excellent business partner from India by providing our customers with superior quality products at highly affordable prices and following that up with reliable service consistently, thereby giving them an unparalleled experience.
Our focus lies in developing new production technologies with a keen interest in frugal innovation in order to gain a competitive edge over others. We specialize in the custom synthesis of molecules and work with many reputed companies around the world on an OEM basis.pharmaceutical pellets,Intermidiates
Our finished formulations from WHO-GMP and EU-GMP units are registered/being registered in 26 countries within Asia, Europe, North America, Latin America and Africa continents including Peru, Panama, Ecuador, Chile, Curaçao, Suriname, Haiti, Aruba, Trinidad, Tobago, Philippines, Myanmar, Laos, Malaysia, Thailand, Indonesia, Hong Kong, Vietnam, Sri Lanka, Maldives, Brunei, Nepal, China, Russia, Croatia, Venezuela and Bhutan.
vishvesh.shaishav@gmail.com

22:36,  22 Jan 2021

jgq@yangzijiang.com

jgq@yangzijiang.com

I am Justin from Yangtze River Pharmaceutical Group in China

APIs and FDF can be manufactured by our company.

We can also CMO

If you need them, please contact me by Tel., WhatsApp and Wechat: +86 15261051195
Email: jgq@yangzijiang.com

10:36,  26 Jan 2021

vishvesh.shaishav@gmail.com

We are focussed on developing new manufacturing technologies, including custom synthesis of new moleculepharma intermediate, catalyst, bulk drugs, pharma API, pharma chemicals, active pharmaceutical ingredients, pharmaceutical pellets,additives, contract manufacturing, chemicals. We began in the field of specialty intermediates for pharmaceutical applications and developed our own purification technologies for manufacturing highly pure intermediates. And Pharmaceutical API At a later stage, we integrated forward to manufacture finished formulations for both veterinary and human consumption. Due to our completely integrated operations in the pharmaceutical sector, we continuously learn about the quality parameters for an API based on the performance of the finished formulation in order to quality their Bioequivalence Studies.
We have established finished formulation lines in South Asian and Latin American countries. It is our vision to achieve worldwide recognition as an excellent business partner from India by providing our customers with superior quality products at highly affordable prices and following that up with reliable service consistently, thereby giving them an unparalleled experience.
Our focus lies in developing new production technologies with a keen interest in frugal innovation in order to gain a competitive edge over others. We specialize in the custom synthesis of molecules and work with many reputed companies around the world on an OEM basis.pharmaceutical pellets,Intermidiates
Our finished formulations from WHO-GMP and EU-GMP units are registered/being registered in 26 countries within Asia, Europe, North America, Latin America and Africa continents including Peru, Panama, Ecuador, Chile, Curaçao, Suriname, Haiti, Aruba, Trinidad, Tobago, Philippines, Myanmar, Laos, Malaysia, Thailand, Indonesia, Hong Kong, Vietnam, Sri Lanka, Maldives, Brunei, Nepal, China, Russia, Croatia, Venezuela and Bhutan.
vishvesh.shaishav@gmail.com

13:29,  26 Jan 2021

phillipsupplies123@gmail.com

Goodwin Planet Pharma Nutrition Supplies Pvt.Co. Limited
Greetings

We are pleased to welcome you to our company . Our products are of high quality and ready for export. Best quality medications at your fingertips on your doorstep. Our company is the home of branded/generic medicines. We are one of the largest manufacturer & exporter of finished medicines & bulk drugs products in pharmaceutical sector in Mumbai, India since last 17 years. We manufacture finished medicines in bulk packing for our buyers as per their requirement. We also supply bulk drugs in wooden cases containers for all pharmaceutical companies. Our company involved in contract manufacturing of finished medicines to international pharmaceutical companies as per their requirements. Our major markets are USA, China, Hong Kong, Malaysia, Indonesia,Taiwan, Philippines, Africa, UK, Middle East, Sri lanka and so many other countries in the world. We deal in bulk quantities and smaller shipments as well. We also provide best fast and reliable service on products like steroids, drugs, supplements, painkillers, chemicals. As per your inquiry , we have it in stock.

07:07,  27 Jan 2021

vinay.pharmanet@gmail.com

Hi,
Vinay is here from Pharmanet India.
We are a professional sourcing company in India. We are sourcing API and FDF from India to UK, Germany, Thailand, Vietnam, Myanmar, Colombia, Chile and lot more countries
Please suggest your requirement. Thanks

16:04,  29 Jan 2021

vvarma@zeonhealth.com

Dear sir

Will.support you finish products .let's know which document require and also qty per shipment .

And also confirm whether u need your brand name or any brand ok..

Regarda
Vinod Varma
Zeon health industries
sales@zeondrugs.com or vvarma@zeonhealth.com

05:43,  01 Feb 2021

export@healthpharma.in


Dear Sir,

Greetings from Health Pharma...!!!

We can support you with your requirements. Kindly request you to send email for detailed information.

Looking forward to your positive response.

Thanks...!!!

12:50,  07 Jul 2021
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty